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Abstract
Osteoporosis constitutes a major public health problem 
through its association with age related fractures. Fracture 
rates are generally higher in caucasian women than in other 
populations. Important determinants include estrogen defi-
ciency in women, low body mass index, cigarette smoking, 
alcohol consumption, poor dietary calcium intake, physical 
inactivity, certain drugs and illnesses. Thus, modification of 
physical activity and dietary calcium/vitamin D nutrition 
should complement high risk approaches. In addition, the 
recently developed WHO algorithm for evaluation of 10-year 
absolute risk of fracture provides a means whereby various 
therapies can be targeted cost-effectively to those at risk. 
Risk factors, together with bone mineral density (BMD) 
and biochemical indices of bone turnover, can be utilised to 
derive absolute risks of fracture and cost-utility thresholds 
at which treatment is justified. These data will provide the 
basis for translation into coherent public health strategies 
aiming to prevent osteoporosis both in individuals and in 
the general population.
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Resumen
La osteoporosis constituye un importante problema de salud 
pública debido a su asociación con fracturas relacionadas con 
la edad. Las tasas de fractura generalmente son más altas en 
mujeres caucásicas que en otros grupos poblacionales. Los 
principales determinantes incluyen deficiencia de estrógeno 
en mujeres, bajo índice de masa corporal, consumo de tabaco 
y alcohol, escaso consumo de calcio, inactividad física y algunas 
drogas y enfermedades. De este modo, la modificación de 
la actividad física y el consumo de nutrimentos con calcio 
y vitamina D deben complementar los tratamientos en alto 
riesgo. Además, el recientemente desarrollado algoritmo de 
la OMS para la evaluación de riesgo de fractura absoluto a 
10 años constituye una herramienta que permite plantear 
eficientemente diversas terapias a aquellos que están en 
riesgo. Los factores de riesgo, junto con la densidad mineral 
ósea y los índices bioquímicos de regeneración ósea pueden 
utilizarse para obtener riesgos de fractura absolutos así como 
umbrales costo-utilidad que justifiquen el tratamiento. Estos 
datos proveerán una base para su traducción en estrategias 
de salud pública con la finalidad de prevenir la osteoporosis 
tanto en los individuos como en la población en general.
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Osteoporosis is a systemic disorder characterised by low bone mass and micro-architectural deteriora-
tion of bone tissue with a consequent increase in bone 
fragility and susceptibility to fracture.1 It has a huge 
impact on public health through the increased mor-
bidity, mortality and economic costs associated with 
fractures. Historically the definition of osteoporosis 
has been difficult. A definition based on bone mineral 
density (BMD) may not encompass all the risk factors 
for fracture, whereas a fracture based definition will not 
enable identification of at risk populations. In 1994, the 
World Health Organisation (WHO) convened to resolve 
this issue, defining osteoporosis in terms of fracture 
and BMD.2 It is important to note that this only takes 
into account the deterioration in mineralisation, and 
does not reflect the decline in micro architecture. More 
recently, there has been a move towards assessment of 
individualised 5 or 10 year absolute risk.3 This has the 
advantage of incorporating risk factors that are partly 
independent of BMD, such as age and previous fracture, 
and thus allows decisions regarding commencement of 
therapy to be made more readily. This article reviews the 
global epidemiology of osteoporosis as well as methods 
to diagnose this disabling condition.
Fracture epidemiology
Fractures of the hip, vertebral body and distal forearm 
have long been regarded as the typical osteoporotic 
fractures. Prospective studies have shown that there is 
a heightened risk of almost all types of fracture in indi-
viduals with low bone density irrespective of fracture 
site. In the year 2000 there were an estimated 9 million 
osteoporotic fractures of which 1.6 million were at the 
hip, 1.7 million at the forearm and 1.4 million were 
clinical vertebral fractures. Worldwide, osteoporotic 
fractures accounted for 0.83% of the global burden of 
non-communicable disease and 1.75% in Europe. In 
Europe, osteoporotic fractures accounted for more 
disability adjusted life years (DALYs) than many other 
chronic non communicable diseases4 (figure 1). 
 A study of British fracture occurrence indicates that 
the population risk is similar in the UK. Thus one in two 
women that are 50 years of age will have an osteoporotic 
fracture in their remaining lifetime; the figure for men is 
one in five.5 The combined annual costs of all osteopo-
rotic fractures have been estimated to be $20 billion in 
the USA and $30 billion in the European Union.6 Fracture 
incidence in the community is bimodal, showing peaks 
in youth and the very elderly (figure 2). In young people, 
fractures of the long bones predominate, usually after 
substantial trauma, and they are more frequent in males 
than females. Over the age of 35 years fracture incidence 
in women rises steeply so that rates become twice those 
in men. Worldwide elderly people represent the fastest 
growing age group, and the yearly number of fractures 
is likely to rise substantially with continued aging of the 
population.
Figure 1: Disability aDjusteD liFe years (Dalys) lost Due to a selection oF non-communicable Diseases in europe. 
(aDapteD From johnell o. Kanis j.)4
Osteoporosis
Ischaemic heart
disease
Chronic obstructive
airways disease
Osteoarthritis
Asthma
Rheumatoid
arthritis
1000                           2000                             3000
2005
15751
3453
3088
1359
1048
DALYs (000)
Artículo de revisión
S40 salud pública de méxico / vol. 51, suplemento 1 de 2009
Cole ZA y col.
Hip fracture
Hip fractures are the most devastating result of os-
teoporosis: they require the patient to be admitted to 
hospital and cause significant morbidity and mortality. 
Most hip fractures take place after a fall from standing 
height, 80% occur in women and 90% in people older 
than 50 years. The incidence increases exponentially 
with age (figure 1) as a result of age related decrease in 
bone mass at the proximal femur and the age related 
increase in falls. Worldwide there were an estimated 1.66 
million hip fractures in 1990. This has been estimated to 
rise to 6.3 million by 2050 with the increasing number 
of elderly people in the population.7 The lifetime risk 
of hip fracture for 50 year olds in the UK is 11.4% and 
3.1% for women and men respectively. Most of this risk 
is accrued in old age, such that a 50 year old woman’s 
10 year risk of hip fracture is 0.3% rising to 8.7% when 
she is 80 years old. The corresponding figures for men 
are 0.2 and 2.9% respectively.5
 Hip fracture mortality is higher in men than women 
and increases with age.8 It is greatest in those with co- 
existing illnesses and poor pre-fracture function. The 
risk of death is greatest after fracture and decreases 
gradually with time. In the United Kingdom the 12 
month survival for hip fracture for men is 63.3% versus 
90.0% expected and for women 74.9% versus 91.1% 
expected.5 Hip fractures result in significant morbidity. 
Patients are prone to developing complications such as 
pressure sores and bronchopneumonia. Fifty percent of 
those ambulatory before the fracture are unable to walk 
independently afterward. Age is an important determi-
nant of outcome, with 14% of 50-55 year old hip fracture 
patients being discharged to nursing homes versus 55% 
of those aged >90 years old.9
Vertebral fracture
Only about a third of all radiographically identified 
vertebral deformities come to specialist attention. There 
is also disagreement about the radiographic definition 
of deformities in those that do present. Thus in studies 
using radiographic screening of populations, vertebral 
deformities have been estimated to be three times that 
Figure 2: raDiographic vertebral, hip anD wrist Fracture inciDence by age anD genDer5
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of hip fracture. Data from the prospective European 
Vertebral Osteoporosis Study (EVOS) have allowed 
accurate assessment of radiographically determined 
vertebral factures in a large population.10 The overall age 
adjusted incidence of vertebral fractures was 5.7/1000 
person years for men and 10.7/1000 person years for 
women. The age standardised prevalence was 12.2% 
for men and 12.0% for women 50-79 years old. Histori-
cally it was believed that vertebral fractures were more 
common in women, but the EVOS data suggest that 
this is not the case at younger ages, possibly because 
of a higher incidence of trauma in men (figure 3). Only 
around a quarter of vertebral fractures result from falls, 
most result from routine activities such as bending or 
lifting light objects.11 In contrast to hip fractures, excess 
mortality after vertebral fracture seems to increase 
progressively after diagnosis of fracture. In the UK the 
observed survival in women 12 months after fracture 
was 86.5% versus 93.6% expected. At 5 years it was 
56.5% observed and 69.9% expected.5 The impact of a 
single vertebral fracture may be low but multiple frac-
tures can cause progressive loss of height and kyphosis 
and severe back pain in the acute stages. Quality of life 
scores decrease as the number of vertebral fractures 
increases.12
Distal forearm fracture
Wrist fractures show a different pattern of occurrence 
to hip and vertebral fractures. Incidence increases in 
white women between the ages of 45 and 60 years, 
followed by a plateau. This may relate to altered 
neuromuscular reflexes with ageing, and as a result, a 
tendency to fall sideways or backwards, and thus not 
to break the fall with an outstretched arm. Most wrist 
fractures occur in women and 50% occur in women 
over 65 years old. Data from the GPRD show that a 
woman’s lifetime risk of wrist fracture at 50 years old is 
16.6%, falling to 10.4% at 70 years. The incidence in men 
is low and does not rise much with ageing (lifetime risk 
2.9% at age 50 years and 1.4% at age 70 years).5 Wrist 
fractures do not seem to increase mortality although 
wrist fractures may impact on some activities such as 
writing or meal preparation.
Clustering of fractures in individuals
Epidemiological studies suggest that patients with dif-
ferent types of fragility fractures are at increased risk 
of developing other types of fracture. For example, the 
presence of a previous vertebral deformity leads to a 7 
to 10 fold increase in the risk of subsequent vertebral 
deformities.13 This is a comparable level of increased 
risk to that seen for individuals who have sustained one 
hip fracture to then sustain a second. Furthermore, data 
from Rochester, Minnesota, suggest that the risk of a hip 
fracture is increased 1.4 fold in women and 2.7 fold in 
men after the occurrence of a distal forearm fracture.14 
The corresponding figures for subsequent vertebral 
fracture are 5.2 and 10.7.
Time trends and future projections
Life expectancy is increasing around the globe and 
the number of elderly individuals is rising in every 
geographic region. The world population is expected 
to rise from the current 323 million individuals aged 65 
years or over, to 1555 million by the year 2050. These 
demographic changes alone can be expected to increase 
the number of hip fractures occurring among people 
aged 35 years and over worldwide: the incidence is 
estimated to rise from 1.66 million in 1990 to 6.26 mil-
lion in 2050.7 Assuming a constant age-specific rate of 
fracture, as the number of over 65s increases from 32 
million in 1990 to 69 million in 2050, the number of hip 
fractures in the US will increase threefold.7 In the UK, 
the number of hip fractures may increase from 46 000 
in 1985 to 117 000 in 2016.15 An increasingly elderly 
Figure 3: prevalence oF vertebral DeFormity by genDer. 
Data DeriveD From the european vertebral osteo-
porosis survey. (reproDuceD From j bone miner res 
with permission oF the american society For bone anD 
mineral research)10
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population in Latin America and Asia could lead to a 
shift in the geographical distribution of hip fractures, 
with only a quarter occurring in Europe and North 
America7 (figure 4). Such projections are almost certainly 
optimistic considering that increases in the incidence of 
hip fractures have been observed even after adjust ing 
for the growth in the elderly population. Age-adjusted 
rate of hip fracture appears to have levelled off in the 
northern regions of the USA, in parts of Sweden, and 
the UK, there is some evidence to suggest that since 
implementation of osteoporosis screening and treat-
ment programs, the incidence of age adjusted hip 
fractures are now starting to fall.16,17 However fracture 
rates are still rising in some locales18 and subsets of the 
population.19 These discrepancies in secular trends by 
race, gender and age might help identify novel public 
health measures. 
Geography
There is a substantial variation in hip fracture rates 
between populations of a given race or gender. Age 
adjusted rates are highest in Scandinavian and North 
American populations, with almost seven fold lower 
rates in southern European countries.20 Hip fracture 
rates are also lower in Asian and Latin American 
populations21,22 and rates seem to be lower in rural 
areas rather than urban areas in any country.23,24 These 
findings suggest an important role for environmental 
factors in the aetiology of hip fracture. However, factors 
studied so far including smoking, alcohol consumption, 
activity levels, obesity and migration status have failed 
to explain these trends. The EVOS study demonstrated 
a threefold difference in the prevalence of vertebral 
deformities between countries, with the highest rates in 
Scandinavia. The prevalence range between centres was 
7.5-19.8% for men and 6.2-20.7% for women. The differ-
ences were not as great as those seen for hip fracture in 
Europe, some of the differences could be explained by 
levels of physical activity and body mass index.8 
Methods to assess bone health
Dual energy X ray absorptiometry
Dual energy X ray absorptiometry (DXA) employs X 
rays of two energies to produce a projection image of 
the region of interest. From these projection images two 
measures are calculated to determine bone mass: areal 
bone mineral density (g/cm2) and bone mineral content 
(BMC) (g). Studies of DXA measures have confirmed that 
BMC and to a lesser degree BMD is strongly correlated to 
Figure 4: estimateD numbers oF hip Fractures among men anD women in DiFFerent regions oF the worlD in 1990 
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ash weight.25 DXA is commonly performed at the lumbar 
spine and proximal femur. However it can also be mea-
sured at the forearm, the calcaneus and the total body. 
The choice of the appropriate site is based on purpose of 
the measurement and the technology of the equipment 
used. Commercial DXA devices are either general pur-
pose instruments for bone densitometry examinations of 
the axial and peripheral skeleton or peripheral units for 
scans of the forearm and /or calcaneus. The advantages 
of DXA include low radiation dose, low cost, ease of use 
and rapidity of measurement. Peripheral DXA devices 
are being increasingly utilized for BMD measurements 
at the forearm and calcaneus.26 They can be used as a 
pre-selection tool to identify women with low BMD at 
the axial skeleton, thus enabling reduction of the number 
of individuals who need evaluation with axial DXA.27 
These peripheral devices have the advantages of low cost 
and portability. There are however limitations inherent 
to DXA measurements. This two dimensional technique 
can not determine between cortical and trabecular bone, 
and cannot discriminate changes due to bone geometry 
(e.g. increases in the third dimension) from those purely 
due to increased bone density (within a fixed volume 
of bone). Falsely elevated BMD values at the spine can 
occur in patients with degenerative spinal changes, frac-
tures in lumbar vertebrae, scoliosis or aortic calcification. 
There is still controversy as to which site could better 
estimate the risk of low energy fracture. Meta-analysis 
results indicate that BMD measurements at the hip are 
superior in predicting hip fractures compared to BMD 
measurements at other sites.28 The World Health Organi-
sation defines osteoporosis by a T score more than 2SD 
below the peak bone mass; these WHO criteria were 
developed for DXA measurements at the lumbar spine 
hip or forearm.
Quantitative computed tomography
 Quantitative computed tomography (QCT) provides an 
alternative to DXA for the measurement of spine, hip 
and wrist BMD. Quantification of BMD by QCT, like 
DXA, is based on the attenuation of the X ray beam as 
it passes through the body. Each slice in CT represents 
tissue volume and thus a volumetric BMD can be at-
tained. This is an advantage in studies with children and 
adolescents where DXA may underestimate BMD due 
to the growth-related variations in bone size. The other 
main advantage of QCT is its ability to assess separately 
cortical and trabecular bone. Compared to DXA, QCT 
provides similar or better results in prediction of spinal 
fracture in that the effects of degenerative disease or 
aortic calcification can be excluded.29 QCT has not been 
used widely in clinical practice because of its high cost 
hardware, the increased demand for CT whole body 
examinations in a clinical environment and the higher 
radiation dose relative to DXA.
Peripheral quantitative computed tomography
A recent development in QCT technology is the avail-
ability of peripheral scanners (pQCT). These scanners 
provide three dimensional mineralisation data in ap-
pendicular sites, commonly the distal radius and distal 
tibia. As with traditional QCT, trabecular and cortical 
compartments can be isolated and studied individually. 
Additionally they present a lower radiation dose to the 
central body scans. The main advantage is the low in-
vestment and running costs. PQCT measurement at the 
distal radius showed moderate correlation with BMD at 
the hip and spine.30,31 The greatest advantage of the ma-
chines is the ability to image at a resolution that allows 
for trabecular visualisation allowing for differences to 
be picked up in osteopenic women that have fractured 
at the wrist compared to those without,32 DXA is unable 
to differentiate between these groups.
Quantitative ultrasound
Quantitative ultrasound(QUS) has been introduced 
recently for measuring bone density in the appendicular 
skeleton. Measurements are performed primarily at the 
calcaneus. It is a technique that uses non-ionising sound 
waves to detect mineral density. Transducers transmit 
ultrasound energy that travels through the bone to 
the receiving transducer. Two measures are produced: 
Broadband ultrasound attenuation (BUA) and speed 
of sound (SOS). QUS measures are well correlated 
with BMD derived from calcaneal DXA scans, and 
can discriminate healthy from osteoporotic groups.33 
However a significant false negative rate has been 
detected. Several studies have documented the ability 
of QUS measurements to estimate fracture risk.34,35 A 
recent study has suggested that BUA predicts osteo-
porotic fractures better than DXA and independently 
of BMD.36 Interest in QUS methods can be attributed 
primarily to the fact that they involve no radiation 
exposure. Additionally they are inexpensive and por-
table. The main disadvantage is lack of sensitivity,37 
making it inappropriate for long term monitoring of 
osteoporosis. Currently ultrasound assessment is used 
as a screening tool, with confirmation of diagnosis via 
DXA evaluation.
Artículo de revisión
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Biochemical markers
Several serum and urine biochemical markers of bone 
turnover have been developed. These provide non-
invasive and fairly inexpensive methods for assessing 
rates of bone formation and resorption in vivo. The 
most widely available markers include serum bone 
specific alkaline phosphatase and the amino terminal 
propeptide of type 1 procollagen, which are markers 
of bone formation, and urine or serum telopeptides of 
collagen crosslinks, which are the markers for bone 
resorption. Disadvantages include their indication of 
whole body bone turnover (mainly cortical bone) and 
day-to-day variability. Despite drawbacks these markers 
can be used to study the pathogenesis of osteoporosis, 
predict the risk of future fracture and predict and moni-
tor response to therapy. Prospective studies have shown 
an association of osteoporotic fracture with indices of 
bone turnover independent of BMD in menopausal 
and elderly women.38 In elderly women with values 
for resorption markers exceeding the reference range 
for premenopausal women, fracture risk is increased 
two fold after adjustment for BMD, thus a combined 
approach could improve fracture prediction.39
Assessment of fracture risk
The WHO scientific group recently convened to develop 
more ways to assess fracture risk. The rationale for this 
initiative is that T scores are insufficient to predict frac-
ture risk. Although the T score has many good attributes: 
it is simple and widely used, it has good correlation with 
fracture risk and it can detect some high risk patients.2 Its 
shortcomings include lack of standardisation regarding 
which skeletal sites to evaluate, lack of generalisation 
to non Caucasian groups and use of BMD as the only 
risk factor evaluated. Inappropriate T score thresholds 
for osteoporosis treatment have incorrectly identified 
patients who are not at high risk of fractures whilst 
missing many who are at increased risk.40 Several other 
clinical risk factors contribute to fracture risk, in part 
independently of BMD. These include age, prior fragility 
fracture, premature menopause, a family history of hip 
fracture and the use of corticosteroids. Since several of 
these risk factors are partly independent on BMD, their 
use in conjunction with BMD improves sensitivity of 
fracture prediction without adverse effects on specific-
ity. The combined use of these risk factors along with 
age and BMD can be used in multivariate models to 
estimate the 10 year probability of hip and other frac-
tures.41 Thus a woman at age 60 years with an average 
BMD (about –1.4) has an average 10 year probability of 
hip fracture at around 2.4%. If she has previously had a 
fragility fracture this risk increased to 4.8%. Intervention 
thresholds will be set by the global cost effectiveness 
model allowing individual countries to determine how 
to utilise these interventions. The WHO initiative have 
concluded from recent population based studies that 
clinical risk factors can be used to enhance the perfor-
mance characteristics of BMD. However application of 
these models will require the incorporation of hazard 
functions of death and calibration to the epidemiology 
of specific countries.42 
Conclusion
Osteoporosis is a disease that has a huge impact on 
global public health. The impact of osteoporotic fracture 
is massive, not just for individuals, but for the health 
service economy, and population as a whole. The char-
acterisation of some of the risk factors for osteoporotic 
fractures have been elucidated, as a result the assess-
ment of patients at high risk of fracture can be identified 
by use of algorithms and appropriate preventative and 
therapeutic strategies implemented. 
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